| 1 |
21861543 | Nilotinib: in the first-line treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia in chronic phase. | 2011 Aug 20 |
1 |
| 2 |
19920925 | Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. | 2009 Sep 21 |
1 |
| 3 |
18956997 | Nilotinib: a new tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia. | 2008 Nov |
1 |
| 4 |
17613767 | The tyrosine kinase inhibitor AMN107 (Nilotinib) exhibits off-target effects in lymphoblastic cell lines. | 2007 Jul |
1 |
| 5 |
16000593 | AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has in vitro activity against imatinib-resistant chronic myeloid leukemia. | 2005 Jul 1 |
1 |
| 6 |
16078266 | AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells. | 2005 Sep 15 |
1 |
| 7 |
11512149 | Mechanisms of resistance imatinib (STI571) in preclinical models and in leukemia patients. | 2001 Feb |
1 |